Injectable obesity medications cause muscle and bone loss alongside fat reduction, clinician states

Clinical nutritionist Silvia Zorrilla outlined risks and care guidance for the treatments on 3 November 2026.

Sarah Lindqvist-Park

Clinical Nutrition Writer

Share on X

Stands on 3 placed sources from 2 publishers.

Clinical nutritionist Silvia Zorrilla has stated that injectable obesity medications cause loss of muscle mass and bone mass alongside fat reduction. ^[1] Zorrilla recommended medical supervision, proper diet and physical exercise alongside injectable obesity treatment. ^[2] Menopause hormone therapy medications are FDA approved for menopause symptoms. These products are not approved for weight loss or obesity management. ^[3]

Proof3 sources · 2 publishers · signed

What this stands on

Clinical nutritionist Silvia Zorrilla stated that injectable obesity medications can cause loss of muscle mass and bone mass alongside fat reduction. · El Día
Silvia Zorrilla recommended medical supervision, proper diet and physical exercise alongside injectable obesity treatment. · El Día
Menopause hormone therapy medications are FDA approved for menopause symptoms but not approved for weight loss or obesity management. · Healthline Media

We could not place any of them by their address. None is an official body: that part stands on reporting, not on the underlying document or transcript.